Jansen Valerie Malyvanh
SEC insider (Form 3/4/5 filer). CIK 0001889716. Director at OnKure Therapeutics, Inc. (OKUR) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in BOULDER, CO.
Companies Jansen Valerie Malyvanh has filed insider reports for
- OnKure Therapeutics, Inc. (OKUR): Director
- Elevation Oncology, Inc. (ELEV): Officer, CHIEF MEDICAL OFFICER
Jansen Valerie Malyvanh
CIK: 0001889716
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
22.4K shares- - Jun 4, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
7.7K shares- - May 28, 2025OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
7.7K shares- - Feb 15, 2025ELEV
Elevation Oncology, Inc.
ExerciseDirect17.5K shares- - Feb 15, 2025ELEV
Elevation Oncology, Inc.
Tax PaymentDirect5.2K shares at avg. $0.67$3K - Feb 15, 2025ELEV
Elevation Oncology, Inc.
AwardDirectStock Option (Right to Buy)
275K shares- - Oct 4, 2024OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
15.3K shares- - Feb 15, 2024ELEV
Elevation Oncology, Inc.
ExerciseDirectRestricted Stock Unit
17.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 |  OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 22,350 | - | - | Direct |
| Jun 4, 2026 | OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 7,650 | - | - | Direct |
| May 28, 2025 | OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 7,650 | - | - | Direct |
| Feb 15, 2025 |  ELEV Elevation Oncology, Inc. | Exercise | 17,500 | - | - | Direct |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | Tax Payment | 5,189 | $0.67 | $3,485 | Direct |
| Feb 15, 2025 | ELEV Elevation Oncology, Inc. | Award Stock Option (Right to Buy) | 275,000 | - | - | Direct |
| Oct 4, 2024 | OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 15,300 | - | - | Direct |
| Feb 15, 2024 | ELEV Elevation Oncology, Inc. | Exercise Restricted Stock Unit | 17,500 | - | - | Direct |
1-8 of 8 transactions